MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Clinical trials for MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in people with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control the disease. About 134 adults will take part across t…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug FOG-001 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug, FOG-001, in about 595 people with advanced solid tumors that have not responded to other treatments. The goal is to see if FOG-001 is safe and can shrink tumors or slow their growth. The trial focuses on several cancer types, including colorectal, pro…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Scientists hunt for clues to immunotherapy resistance in bowel cancer
Knowledge-focused Recruiting nowThis study is for people with a specific type of advanced colorectal cancer called MSI. It aims to find out why about 20-30% of patients do not respond to the immunotherapy drug pembrolizumab. By studying 600 participants, researchers hope to identify markers that predict resista…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC